| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 46.7669 | 36 |
| GSM780708 | Untreated after 4 days (C2_1) | 48.5812 | 43 |
| GSM780709 | Untreated after 4 days (C3_1) | 50.7626 | 51 |
| GSM780719 | Untreated after 4 days (C1_2) | 47.5889 | 39 |
| GSM780720 | Untreated after 4 days (C2_2) | 53.1968 | 56 |
| GSM780721 | Untreated after 4 days (C3_2) | 46.7868 | 36 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 41.3471 | 11 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 44.8052 | 26 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 50.6051 | 50 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 47.1061 | 37 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 55.2606 | 60 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 51.0298 | 51 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 77.2923 | 71 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 44.2775 | 23 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 85.9808 | 73 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 79.7618 | 72 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 49.2463 | 46 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 92.89 | 74 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 45.3715 | 29 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 66.7478 | 68 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 44.2471 | 23 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 47.8223 | 40 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 52.6273 | 55 |